Can treatment-as-prevention and PrEP reduce HIV incidence?

Lancet HIV. 2023 Jun;10(6):e355-e356. doi: 10.1016/S2352-3018(23)00083-8. Epub 2023 Apr 15.

Authors

Nittaya Phanuphak¹, Praphan Phanuphak²

Affiliations

¹ Institute of HIV Research and Innovation (IHRI), Bangkok, Thailand. Electronic address: nittaya.p@ihri.org.
² Institute of HIV Research and Innovation (IHRI), Bangkok, Thailand.

PMID: 37068497
DOI: 10.1016/S2352-3018(23)00083-8

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents* / therapeutic use
HIV Infections* / drug therapy
HIV Infections* / epidemiology
HIV Infections* / prevention & control
Humans
Incidence
Pre-Exposure Prophylaxis*

Substances

Anti-HIV Agents